Catalyst Funds Management Pty LTD Biogen Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Biogen Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 600 shares of BIIB stock, worth $98,933. This represents 0.03% of its overall portfolio holdings.
Number of Shares
600Holding current value
$98,933% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,031Shares Held
126MCall Options Held
1.04MPut Options Held
1.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.75 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.69 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.4 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.21 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$846 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...